Advances in Hematology / 2014 / Article / Tab 2

Research Article

Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin’s Primary Bone Lymphoma

Table 2

Univariate and multivariate analyses of characteristics affecting survival of adults with non-Hodgkin primary bone lymphoma.

CharacteristicsUnivariate analysis Multivariate analysis
mean ± SD

10-year OS, %
Trial
 02 nsns
 03
Epidural extension
 No nsns
 Yes
PS ≥2
 No 0.046ns
 Yes
10-year EFS, %
Trial
 02 nsns
 03
Epidural extension
 No nsns
 Yes
PS ≥2
 No 0.0380.018
 Yes

OS: overall survival; PS: performance status; EFS: event-free survival; ns: not significant.
Other studied factors (gender, stage, B symptoms, site, lactatedehydrogenase level, and bulky disease) do not have significantly statistical prognosis.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.